MMP2 and hepatocellular carcinoma: The loss of miR-320a inhibits the miR-320a-PBX3-MAPK pathway and induce epithelial– mesenchymal transformation and the matrix metalloproteinase 2 (MMP-2) expressions to promote HCC progression and metastasis [316].